Show simple item record

dc.contributor.authorCardwell, Francesca S.
dc.contributor.authorElliott, Susan J.
dc.contributor.authorChin, Ricky
dc.contributor.authorSt Pierre, Yvan
dc.contributor.authorChoi, May Y.
dc.contributor.authorUrowitz, Murray B.
dc.contributor.authorRuiz Irastorza, Guillermo
dc.contributor.authorBernatsky, Sasha
dc.contributor.authorWallace, Daniel J.
dc.contributor.authorPetri, Michelle A.
dc.contributor.authorManzi, Susan
dc.contributor.authorBae, Sang-Cheol
dc.contributor.authorShin, Jung-Min
dc.contributor.authorMak, Anselm
dc.contributor.authorCho, Jiacai
dc.contributor.authorPeschken, Christine A.
dc.contributor.authorRamsey-Goldman, Rosalind
dc.contributor.authorFortin, Paul R.
dc.contributor.authorHanly, John G.
dc.contributor.authorPons-Estel, Bernardo A.
dc.contributor.authorNieto, Romina
dc.contributor.authorAskanase, Anca D.
dc.contributor.authorRomero Díaz, Juanita
dc.contributor.authorMosca, Marta
dc.contributor.authorBruce, Ian N.
dc.contributor.authorRowbottom, Leigha
dc.contributor.authorMielczarek, Leanne
dc.contributor.authorTse, Karin
dc.contributor.authorMarion, Ashley
dc.contributor.authorCahiz González, Juan Carlos
dc.contributor.authorCattoni, Teresa G.
dc.contributor.authorCornet, Alain
dc.contributor.authorClarke, Ann Elaine
dc.date.accessioned2022-12-15T16:16:31Z
dc.date.available2022-12-15T16:16:31Z
dc.date.issued2022
dc.identifier.citationLupus Science & Medicine 9(1) : (2022) // Article ID e000755es_ES
dc.identifier.issn2053-8790
dc.identifier.urihttp://hdl.handle.net/10810/58842
dc.description.abstractObjective We conducted an international survey of patients with SLE to assess their access, preference and trust in various health information sources pre-COVID-19 and during the COVID-19 pandemic. Methods Patients with SLE were recruited from 18 observational cohorts, and patients self-reporting SLE were recruited through five advocacy organisations. Respondents completed an online survey from June 2020 to December 2021 regarding the sources of health information they accessed in the 12 months preceding (pre-11 March 2020) and during (post-11 March 2020) the pandemic. Multivariable logistic regressions assessed factors associated with accessing news and social media post-11 March 2020, and self-reporting negative impacts from health information accessed through these sources. Results Surveys were completed by 2111 respondents; 92.8% were female, 76.6% had postsecondary education, mean (SD) age was 48.8 (14.0) years. Lupus specialists and family physicians were the most preferred sources pre-11 March 2020 and post-11 March 2020, yet were accessed less frequently (specialists: 78.5% pre vs 70.2% post, difference -8.3%, 95% CI -10.2% to -6.5%; family physicians: 57.1% pre vs 50.0% post, difference -7.1%, 95% CI -9.2% to -5.0%), while news (53.2% pre vs 62.1% post, difference 8.9%, 95% CI 6.7% to 11.0%) and social media (38.2% pre vs 40.6% post, difference 2.4%, 95% CI 0.7% to 4.2%) were accessed more frequently post-11 March 2020 vs pre-11 March 2020. 17.2% of respondents reported negative impacts from information accessed through news/social media. Those outside Canada, older respondents or with postsecondary education were more likely to access news media. Those in Asia, Latin America or younger respondents were more likely to access social media. Those in Asia, older respondents, males or with postsecondary education in Canada, Asia or the USA were less likely to be negatively impacted. Conclusions Physicians, the most preferred and trusted sources, were accessed less frequently, while news and social media, less trusted sources, were accessed more frequently post-11 March 2020 vs pre-11 March 2020. Increasing accessibility to physicians, in person and virtually, may help reduce the consequences of accessing misinformation/disinformation.es_ES
dc.language.isoenges_ES
dc.publisherBMJes_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc/3.0/es/*
dc.subjectlupus erythematosuses_ES
dc.subjectsystemices_ES
dc.subjectCOVID-19es_ES
dc.subjecthealth services researches_ES
dc.titleHealth information use by patients with systemic lupus erythematosus (SLE) pre and during the COVID-19 pandemices_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.holder© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.es_ES
dc.rights.holderAtribución-NoComercial 3.0 España*
dc.relation.publisherversionhttps://lupus.bmj.com/content/9/1/e000755es_ES
dc.identifier.doi10.1136/lupus-2022-000755
dc.departamentoesMedicinaes_ES
dc.departamentoeuMedikuntzaes_ES


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
Except where otherwise noted, this item's license is described as © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.